McLean, VA (PRWEB) September 22, 2013
RxAnte, Inc, today announced the general availability of RxEffect™, the newest application of its patent-pending predictive analytics and decision support suite of products. Health plans, PBMs, delivery systems, and community pharmacies use RxEffect to engage with health care providers to improve medication use in their populations.It delivers timely, practical action steps for each high-priority patient directly to physician practices and community pharmacies, minimizing data and incentive barriers that have historically inhibited effective provider engagement for medication quality outcomes.
“Health plans and PBMs have a lot of options for delivering their own direct-to-member communications regarding medication outcomes. However, some patients at elevated risks of suboptimal outcomes need active, prevention-oriented engagement by their own trusted health care professionals: doctors, nurses, and pharmacists. We built RxEffect to identify the patients who most need support, and then deliver targeted, timely information to the health care providers who are best positioned to provide that support,” said Aaron McKethan, PhD, senior vice president, strategy and business development for RxAnte.
RxEffect is different from traditional pay-for-performance methods and health care quality dashboards that offer providers too much information on behalf of too many patients, small incentives, and no practical action steps to help providers engage patients for better outcomes. Utilizing RxAnte’s analytics tools, RxEffect accurately predicts the subsets of patients who most need support, and then delivers patient-specific decision support for relevant physician practices in near real time. In addition, the secure web-based tool facilitates timely and informed patient outreach, offers tracking and benchmarking tools, and facilitates two-way communication with physician practices and community pharmacies.
“Most pay-for-performance programs offer physician practices very small incentives in exchange for delivering extra support to large panels of patients,” McKethan said. “Because we can identify the subsets of patients whose future adherence is at risk before they become non-adherent, we can help health plans give their health care providers the information they need to engage patients on a more targeted, personalized, and effective basis.”
RxAnte began piloting this new offering with a large national health plan in July 2013. Since its inception, over 3,000 unique prescribers from nearly 600 physician practices across over 20 states are actively using RxEffect.
To set up a media interview with an RxAnte leader, contact Leigh Canavan at (703) 677-6459. RxAnte will also be showcasing RxEffect at America’s Health Insurance Plans’ Medicare and Medicaid Conferences in Washington, DC September 22-26, 2013 in booth #26.
RxAnte is a health technology company with an innovative analytics platform that is transforming how organizations work with health care professionals, care management intervention providers, and patients to improve the use of safe and effective prescription medications. Created by subject matter experts in medication adherence, health IT, and advanced analytics, the “RxAnte System” is a patent-pending process that includes predictive and decision analytics, advanced evaluation methods, and an innovative platform for provider engagement. Learn more at http://www.rxante.com or follow us on Twitter.